Defining the population-based burden of nosocomial pneumococcal bacteremia

Archives of Internal Medicine

Volumn 167, Issue 15, 2007, Pages 1635-1640

  Lyytikäinen, Outi ^a   Klemets, Peter ^a   Ruutu, Petri ^a   Kaijalainen, Tarja ^a   Rantala, Merja ^a   Ollgren, Jukka ^a   Nuorti, J Pekka ^a,b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; FATALITY; FEMALE; FINLAND; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STREPTOCOCCUS INFECTION;

ADOLESCENT; ADULT; AGED; BACTEREMIA; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS;

EID: 34548014328     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.15.1635     Document Type: Article

References (24)

1. Paradisi F, Corti G. Is Streptococcus pneumoniae a nosocomially acquired pathogen? Infect Control Hosp Epidemiol. 1998;19(8):578-580.
2. Paradisi F, Corti G, Cinelli R. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains. Clin Microbiol Infect. 2001;7(suppl 4):34-42.
3. Nuorti JP, Butler JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med. 1998;338(26):1861-1868.
4. Gleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol. 2000;21(11):711-717.
5. Carter RJ, Sorenson G, Heffernan R, et al; MDRSP Working Group. Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a longterm-care facility: emergence and ongoing transmission. Infect Control Hosp Epidemiol. 2005;26(3):248-255.
6. Fry AM, Udeagu CCN, Soriano-Gabarro M, et al. Persistence of fluoroquinoloneresistant, multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: efforts to reduce intrafacility transmission. Infect Control Hosp Epidemiol. 2005;26(3):239-247.
7. Kupronis BA, Richards CL, Whitney CG; Active Bacterial Core Surveillance Team. Invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc. 2003;51(11):1520-1525.
8. Mylotte JM, Beam TR Jr. Comparison of community-acquired and nosocomial pneumococcal bacteremia. Am Rev Respir Dis. 1981;123(3):265-268.
9. Alvarez S, Guarderas J, Shell CG, Holtsclaw-Berk S, Berk SL. Nosocomial pneumococcal bacteremia [published correction appears in Arch Intern Med. 1988;148(6):1279]. Arch Intern Med. 1986;146(8):1509-1512.
10. Chang JI, Mylotte JM. Pneumococcal bacteremia: update from an adult hospital with a high rate of nosocomial cases. J Am Geriatr Soc. 1987;35(8):747-754.
11. García-Leoni ME, Cercenado E, Rodeno P, Bernaldo de Quiros JC, Martinez-Hernandez D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis. 1992;14(2):427-435.
12. Rubins JB, Cheung S, Carlson P, Bloomfield Rubins H, Janoff EN. Identification of clinical risk factors for nosocomial pneumococcal bacteremia. Clin Infect Dis. 1999;29(1):178-183.
13. Fariñas-Alvarez C, Fariñas MC, García-Palomo JD, et al. Prognostic factors for pneumococcal bacteremia in a university hospital. Eur J Clin Microbiol Infect Dis. 2000;19(10):733-741.
14. Canet JJ, Juan N, Xercavins M, Freixas N, Garau J. Hospital-acquired pneumococcal bacteremia. Clin Infect Dis. 2002;35(6):697-702.
15. Maugein J, Guillemot D, Dupont MJ, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect. 2003;9(4):280-288.
16. Bouza E, Pintado V, Rivera S, et al; Spanish Pneumococcal Infection Study Network (G03/103). Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11(11):919-924.
17. Kilpi T, Herva E, Kaijalainen T, Syrjanen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20(7):654-662.
18. Pihlajamäki M, Jalava J, Huovinen P, Kotilainen P; Finnish Study Group for Antimicrobial Resistance. Antimicrobial resistance of invasive pneumococci in Finland in 1999-2000. Antimicrob Agents Chemother. 2003;47(6):1832-1835.
19. National Public Health Institute. Rokottajan käsikirja 2005 [Vaccinator's Manual 2005]. Helsinki, Finland: Kustannus Oy Duodecim; 2005. http://www.ktl.fi/portal/suomi/julkaisut/oppaat_ja_kirjat/rokottajan_kasikirja/ taulukot/taulukko_30/. Accessed April 26, 2007.
20. National Public Health Institute. Infectious diseases in Finland 2002. 2003. http://www.ktl.fi/attachments/suomi/julkaisut/julkaisusarja_b/2003b10.pdf. Accessed September 25, 2006.
21. Nuorti JP, Butler JC, Farley MM, et al; Active Bacterial Core Surveillance Team. Cigarette smoking and invasive pneumococcal disease N Engl J Med. 2000;342(10):681-689.
22. Ruutu P, Kuusi M, Nuorti PJ, Koskinen S. Communicable diseases. In: Aromaa A, Koskinen S, eds. Health and Functional Capacity in Finland: Baseline Results of the Health 2000 Examination Survey. Helsinki, Finland: National Public Health Institute; 2004.
23. Rubins JB, Alter M, Loch J, Janoff EN. Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun. 1999;67(11):5979-5984.
24. Lexau CA, Lynfield R, Danila R, et al; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294(16):2043-2051.